Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3527-3535

Bentham Science Publishers

Access to resources Recommend Favorite

Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus

By Wright R.A.   Schoepp D.D.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 275-282

Elsevier

Access to resources Recommend Favorite

New structures able to prevent the inhibition by hydroxyl radicals of glutamate transport in cultured astrocytes

By Cauquil-Caubere I.   Kamenka J.-M.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 11, 1998-11 ,pp. : 867-877

Elsevier

Access to resources Recommend Favorite

Presynaptic modulation by VIP, secretin and isoproterenol of somatostatin release from enriched enteric synaptosomes: role of cAMP

By Kurjak M.   Schusdziarra V.   Allescher H.-D.  

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite

Changes in the subcellular distribution of cAMP receptors after chronic treatment with fluvoxamine and paroxetine

By Mori S.   Caivano M.   Garbini S.   Dorigo A.   Zanardi R.   Perez J.   Racagni G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 279-280

Elsevier

Access to resources Recommend Favorite